在吸烟的艾滋病毒感染者中预装尼古丁替代疗法:试点随机对照试验
Patricia A Cioe1, Garrett S Stang1, Danish Azam1
1Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI.
概括
尼古丁替代疗法 (NRT) 预加载对于吸烟的艾滋病毒感染者 (PWH) 是可行的和可以接受的. 虽然它没有增加戒断率,但它改善了药物坚持和减少了PWH中吸烟.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
- 艾滋病毒研究 艾滋病毒研究
背景情况:
- 与普通人群相比,艾滋病毒感染者 (PWH) 的戒烟率较低.
- 基于证据的治疗方法在PWH吸烟者中表现出有限的成功.
- 这项研究调查了尼古丁替代疗法 (NRT) 预加载,以改善PWH的戒断结果.
研究的目的:
- 检查在PWH中NRT预加载的可行性和可接受性.
- 评估NRT预加载对戒烟结果的初步疗效.
- 评估对NRT的坚持和戒烟的自我有效性.
主要方法:
- 一项为期16周的研究将49个PWH随机分配给NRT预加载 (NRT-P) 或标准治疗 (ST).
- 在目标戒烟日期 (TQD) 之前,NRT-P涉及3周的尼古丁贴片使用.
- 所有参与者都接受了NRT和行为辅导的组合;在第16周,通过生化验证了禁欲.
主要成果:
- 预装NRT显示出出色的可行性和可接受性,并具有很高的坚持.
- 参与NRT-P组的参与者在TQD后显著更好地遵守尼古丁贴片.
- NRT-P与减少每周吸烟量和降低一氧化碳水平有关,同时增加了戒烟的自我有效性.
结论:
- 对吸烟的PWH来说,NRT预加载是一种可行的和可以接受的干预措施.
- 预加载可以提高戒烟药物的坚持,并减少吸烟依赖.
- 需要进一步的研究来确定NRT预加载是否可以提高PWH吸烟戒断率.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Stimulants
848
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
848
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
466
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
466
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K


